Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology) Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology)

Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology‪)‬

Clinical Chemistry 1997, Jan, 43, 1

    • $5.99
    • $5.99

Publisher Description

Five drug classes are monitored by the Substance Abuse and Mental Health Services Administration (SAMHSA), the federally regulated, civilian drug-testing program: cocaine (COC), marijuana (THC), amphetamines, phencyclidine, and opiates. (1) COC and THC are of primary interest because of their relatively high incidence, which is the result almost exclusively of abuse, their medical use being extremely limited. For the first 4 years after the inception of the SAMHSA drug-testing program, the initial testing (screening) and confirmation testing cutoffs for THC were 100 [micro]g/L and 15 [micro]g/L, respectively [1]; on September 1, 1994, the initial testing cutoff for cannabinoids was decreased to 50 [micro]g/L [2]. The initial testing and confirmation SAMHSA cutoffs for COC have remained at 300 [micro]g/L and 150 [micro]g/L, respectively. None of the other major civilian drug-testing programs such as the College of American Pathologists or New York State have mandatory reporting cutoffs for the urine drug-testing laboratories enrolled in their programs. The Department of Defense drug-testing program uses respective initial and confirmation test cutoffs of 50 and 15 [micro]g/L for THC and of 150 and 100 [micro]g/L for COC. The present study was undertaken to determine what cutoffs are obtainable with the methodologies now in use for COC and THC and whether applying lower cutoffs would lead to a significant increase in the rates of positive results found. Materials and Methods

GENRE
Science & Nature
RELEASED
1997
1 January
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
210.9
KB

More Books Like This

Interference with Testing for Lysergic Acid Diethylamide (Drug Monitoring and Toxicology) Interference with Testing for Lysergic Acid Diethylamide (Drug Monitoring and Toxicology)
1997
Dried Blood Spots Dried Blood Spots
2014
Analytical Chemistry for Assessing Medication Adherence Analytical Chemistry for Assessing Medication Adherence
2016
Use of On-Site Testing for Drugs of Abuse. Use of On-Site Testing for Drugs of Abuse.
2002
Evaluation and Performance Characteristics of the STA-R Coagulation Analyzer (Technical Briefs) Evaluation and Performance Characteristics of the STA-R Coagulation Analyzer (Technical Briefs)
2002
1,6-Hexamethylene Diamine (Hda) As a Urinary Biomarker for Dermal and Inhalation Exposure to 1,6-Hexamethylene Diisocyanate (Hdi) In Automotive Spray-Painters 1,6-Hexamethylene Diamine (Hda) As a Urinary Biomarker for Dermal and Inhalation Exposure to 1,6-Hexamethylene Diisocyanate (Hdi) In Automotive Spray-Painters
2011

More Books by Clinical Chemistry

Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial) Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial)
2001
Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry) Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry)
2003
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs) Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs)
2002
Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report) Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report)
2007
Errors, Mistakes, Blunders, Outliers, Or Unacceptable Results: How Many?(Laboratory Management) (Clinical Report) Errors, Mistakes, Blunders, Outliers, Or Unacceptable Results: How Many?(Laboratory Management) (Clinical Report)
1997